Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Genet Mol Biol ; 45(3 Suppl 1): e20220107, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36288458

RESUMO

The term "SOS response" was first coined by Radman in 1974, in an intellectual effort to put together the data suggestive of a concerted gene expression program in cells undergoing DNA damage. A large amount of information about this cellular response has been collected over the following decades. In this review, we will focus on a few of the relevant aspects about the SOS response: its mechanism of control and the stressors which activate it, the diversity of regulated genes in different species, its role in mutagenesis and evolution including the development of antimicrobial resistance, and its relationship with mobile genetic elements.

2.
Infect Genet Evol ; 58: 27-33, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-29248795

RESUMO

In the present study, we screened a collection of 77 Proteus mirabilis clinical isolates for the presence of mutators, using the frequency of both rifampicin and fosfomycin resistance mutants as markers of spontaneous mutagenesis. We found that none of the strains in our collection are mutators for the rifampicin resistance (RifR) marker. Nevertheless, a significant fraction of the isolates (17%) show high frequencies of fosfomycin resistant mutants (FosR). We show that this increased mutability to FosR correlates with a low level of resistance to Fosfomycin (MICs 8-64µg/ml). These strains also show high frequencies of single step mutants with clinically relevant FosR resistance levels (MIC ≥256µg/ml). Our findings point out to the risk of fosfomycin resistance emergence in P. mirabilis.


Assuntos
Antibacterianos/farmacologia , Farmacorresistência Bacteriana , Fosfomicina/farmacologia , Mutação , Infecções por Proteus/microbiologia , Proteus mirabilis/efeitos dos fármacos , Proteus mirabilis/genética , Antibacterianos/uso terapêutico , Fosfomicina/uso terapêutico , Humanos , Testes de Sensibilidade Microbiana , Taxa de Mutação , Infecções por Proteus/tratamento farmacológico
3.
DNA Repair (Amst) ; 59: 20-26, 2017 11.
Artigo em Inglês | MEDLINE | ID: mdl-28938097

RESUMO

imuABC (imuAB dnaE2) genes are responsible for SOS-mutagenesis in Caulobacter crescentus and other bacterial species devoid of umuDC. In this work, we have constructed operator-constitutive mutants of the imuABC operon. We used this genetic tool to investigate the effect of SOS-induced levels of these genes upon both spontaneous and damage-induced mutagenesis. We showed that constitutive expression of imuABC does not increase spontaneous or damage-induced mutagenesis, nor increases cellular resistance to DNA-damaging agents. Nevertheless, the presence of the operator-constitutive mutation rescues mutagenesis in a recA background, indicating that imuABC are the only genes required at SOS-induced levels for translesion synthesis (TLS) in C. crescentus. Furthermore, these data also show that TLS mediated by ImuABC does not require RecA, unlike umuDC-dependent mutagenesis in E. coli.


Assuntos
Caulobacter crescentus/metabolismo , Dano ao DNA , Replicação do DNA , RNA Polimerases Dirigidas por DNA/metabolismo , Mutagênese , Resposta SOS em Genética , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Caulobacter crescentus/genética , DNA/metabolismo , RNA Polimerases Dirigidas por DNA/genética
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa